This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Persons, D. L. Articles by Pelling, J. C. Search for Related Content PubMed PubMed Citation Articles by Persons, D. L. Articles by Pelling, J. C.

Cisplatin-induced Activation of Mitogen-activated Protein Kinases in Ovarian Carcinoma Cells: Inhibition of Extracellular Signal-regulated Kinase Activity Increases Sensitivity to Cisplatin¹

Departments of Pathology and Laboratory Medicine [D. L. P., E. M. Y., W. C., J. C. P.] and Biochemistry and Molecular Biology [J. C. P.], University of Kansas Medical Center, Kansas City, Kansas 66160-7410

Cisplatin treatment activates multiple signal transduction pathways, which can lead to several cellular responses including cell cycle arrest, DNA repair, survival, or apoptosis. We investigated the response of the mitogen-activated protein kinases, extracellular signal-regulated kinases 1 and 2 (ERK1/2), c-Jun-N-terminal kinase 1 (JNK1), and p38, to cisplatin treatment in the ovarian carcinoma cell line SK-OV-3. Cisplatin caused a late and prolonged induction in a dose-dependent manner of both ERK1/2 and JNK1 activity. ERK1/2 and JNK1 activities continued to increase in magnitude up to 24 h following initiation of cisplatin treatment. In contrast, cisplatin treatment had no effect on p38 activity. Transplatin failed to induce either ERK1/2 or JNK1 at 24 h, which suggests that the activation of these kinases was dependent on cisplatin-specific DNA damage. Treatment with cycloheximide resulted in inhibition of cisplatin-induced ERK1/2 activation, demonstrating that ERK1/2 activity induced by cisplatin was dependent on de novo protein synthesis. Furthermore, inhibition of cisplatin-induced ERK1/2 activity by PD 98059 caused enhanced cisplatin cytotoxicity. Similar enhanced cytotoxic effects of cisplatin were also observed following treatment with PD 98059 in the ovarian carcinoma cell line UCI 101. These observations indicate that ERK1/2 activation induced by cisplatin partially protects cells from cisplatin cytotoxicity. Continued investigation into the mechanism by which the ERK pathway and other signal transduction pathways modulate the response to cisplatin may be helpful in the development of new strategies for improving the therapeutic use of platinum drugs.

This article has been cited by other articles:

				S. A. Matheny and M. A. White Signaling Threshold Regulation by the Ras Effector IMP J. Biol. Chem., April 24, 2009; 284(17): 11007 - 11011. [Abstract] [Full Text] [PDF]

				D. W. Chan, V. W.S. Liu, G. S.W. Tsao, K.-M. Yao, T. Furukawa, K. K.L. Chan, and H. Y.S. Ngan Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells Carcinogenesis, September 1, 2008; 29(9): 1742 - 1750. [Abstract] [Full Text] [PDF]

				P. Sini, I. Samarzija, F. Baffert, A. Littlewood-Evans, C. Schnell, A. Theuer, S. Christian, A. Boos, H. Hess-Stumpp, J. A. Foekens, et al. Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics Cancer Res., March 1, 2008; 68(5): 1581 - 1592. [Abstract] [Full Text] [PDF]

				V. Benedetti, P. Perego, G. Luca Beretta, E. Corna, S. Tinelli, S. C. Righetti, R. Leone, P. Apostoli, C. Lanzi, and F. Zunino Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds Mol. Cancer Ther., March 1, 2008; 7(3): 679 - 687. [Abstract] [Full Text] [PDF]

				T. Panaretakis, L. Hjortsberg, K. P. Tamm, A.-C. Bjorklund, B. Joseph, and D. Grander Interferon {alpha} Induces Nucleus-independent Apoptosis by Activating Extracellular Signal-regulated Kinase 1/2 and c-Jun NH2-Terminal Kinase Downstream of Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin Mol. Biol. Cell, January 1, 2008; 19(1): 41 - 50. [Abstract] [Full Text] [PDF]

				J. Wang, J.-Y. Zhou, and G. S. Wu ERK-Dependent MKP-1 Mediated Cisplatin Resistance in Human Ovarian Cancer Cells Cancer Res., December 15, 2007; 67(24): 11933 - 11941. [Abstract] [Full Text] [PDF]

				S. Rubio, J. Quintana, J. L. Eiroa, J. Triana, and F. Estevez Acetyl derivative of quercetin 3-methyl ether-induced cell death in human leukemia cells is amplified by the inhibition of ERK Carcinogenesis, October 1, 2007; 28(10): 2105 - 2113. [Abstract] [Full Text] [PDF]

				G. Huang, L. Mills, and L. L. Worth Expression of human glutathione S-transferase P1 mediates the chemosensitivity of osteosarcoma cells Mol. Cancer Ther., May 1, 2007; 6(5): 1610 - 1619. [Abstract] [Full Text] [PDF]

				M. Fan, K. M. Ahmed, M. C. Coleman, D. R. Spitz, and J. J. Li Nuclear Factor-{kappa}B and Manganese Superoxide Dismutase Mediate Adaptive Radioresistance in Low-Dose Irradiated Mouse Skin Epithelial Cells Cancer Res., April 1, 2007; 67(7): 3220 - 3228. [Abstract] [Full Text] [PDF]

				L. O. Andrieux, A. Fautrel, A. Bessard, A. Guillouzo, G. Baffet, and S. Langouet GATA-1 Is Essential in EGF-Mediated Induction of Nucleotide Excision Repair Activity and ERCC1 Expression through ERK2 in Human Hepatoma Cells Cancer Res., March 1, 2007; 67(5): 2114 - 2123. [Abstract] [Full Text] [PDF]

				P. C.K. Leung and J.-H. Choi Endocrine signaling in ovarian surface epithelium and cancer Hum. Reprod. Update, March 1, 2007; 13(2): 143 - 162. [Abstract] [Full Text] [PDF]

				G. Ramesh, S. R. Kimball, L. S. Jefferson, and W. B. Reeves Endotoxin and cisplatin synergistically stimulate TNF-{alpha} production by renal epithelial cells Am J Physiol Renal Physiol, February 1, 2007; 292(2): F812 - F819. [Abstract] [Full Text] [PDF]

				K. M. Ahmed, S. Dong, M. Fan, and J. J. Li Nuclear Factor-{kappa}B p65 Inhibits Mitogen-Activated Protein Kinase Signaling Pathway in Radioresistant Breast Cancer Cells Mol. Cancer Res., December 1, 2006; 4(12): 945 - 955. [Abstract] [Full Text] [PDF]

				W. Jia, V. L. Hegde, N. P. Singh, D. Sisco, S. Grant, M. Nagarkatti, and P. S. Nagarkatti {Delta}9-Tetrahydrocannabinol-Induced Apoptosis in Jurkat Leukemia T Cells Is Regulated by Translocation of Bad to Mitochondria Mol. Cancer Res., August 1, 2006; 4(8): 549 - 562. [Abstract] [Full Text] [PDF]

				C. Billecke, S. Finniss, L. Tahash, C. Miller, T. Mikkelsen, N. P. Farrell, and O. Bogler Polynuclear platinum anticancer drugs are more potent than cisplatin and induce cell cycle arrest in glioma Neuro-oncol, July 1, 2006; 8(3): 215 - 226. [Abstract] [Full Text] [PDF]

				J. A. Hickson, D. Huo, D. J. Vander Griend, A. Lin, C. W. Rinker-Schaeffer, and S. D. Yamada The p38 Kinases MKK4 and MKK6 Suppress Metastatic Colonization in Human Ovarian Carcinoma Cancer Res., February 15, 2006; 66(4): 2264 - 2270. [Abstract] [Full Text] [PDF]

				J. Turkson, S. Zhang, L. B. Mora, A. Burns, S. Sebti, and R. Jove A Novel Platinum Compound Inhibits Constitutive Stat3 Signaling and Induces Cell Cycle Arrest and Apoptosis of Malignant Cells J. Biol. Chem., September 23, 2005; 280(38): 32979 - 32988. [Abstract] [Full Text] [PDF]

				D. W.-C. Li, J.-P. Liu, Y.-W. Mao, H. Xiang, J. Wang, W.-Y. Ma, Z. Dong, H. M. Pike, R. E. Brown, and J. C. Reed Calcium-activated RAF/MEK/ERK Signaling Pathway Mediates p53-dependent Apoptosis and Is Abrogated by {alpha}B-Crystallin through Inhibition of RAS Activation Mol. Biol. Cell, September 1, 2005; 16(9): 4437 - 4453. [Abstract] [Full Text] [PDF]

				G. Ramesh and W. B. Reeves p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice Am J Physiol Renal Physiol, July 1, 2005; 289(1): F166 - F174. [Abstract] [Full Text] [PDF]

				J.-H. Choi, K.-C. Choi, N. Auersperg, and P. C K Leung Gonadotropins upregulate the epidermal growth factor receptor through activation of mitogen-activated protein kinases and phosphatidyl-inositol-3-kinase in human ovarian surface epithelial cells Endocr. Relat. Cancer, June 1, 2005; 12(2): 407 - 421. [Abstract] [Full Text] [PDF]

				M. Kim, Y. Yan, R. L. Kortum, S. M. Stoeger, M. K. Sgagias, K. Lee, R. E. Lewis, and K. H. Cowan Expression of Kinase Suppressor of Ras1 Enhances Cisplatin-Induced Extracellular Signal-Regulated Kinase Activation and Cisplatin Sensitivity Cancer Res., May 15, 2005; 65(10): 3986 - 3992. [Abstract] [Full Text] [PDF]

				J. Turkson, S. Zhang, J. Palmer, H. Kay, J. Stanko, L. B. Mora, S. Sebti, H. Yu, and R. Jove Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity Mol. Cancer Ther., December 1, 2004; 3(12): 1533 - 1542. [Abstract] [Full Text] [PDF]

				J.-H. Choi, K.-C. Choi, N. Auersperg, and P. C. K. Leung Overexpression of Follicle-Stimulating Hormone Receptor Activates Oncogenic Pathways in Preneoplastic Ovarian Surface Epithelial Cells J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5508 - 5516. [Abstract] [Full Text] [PDF]

				I. Arany, J. K. Megyesi, H. Kaneto, P. M. Price, and R. L. Safirstein Cisplatin-induced cell death is EGFR/src/ERK signaling dependent in mouse proximal tubule cells Am J Physiol Renal Physiol, September 1, 2004; 287(3): F543 - F549. [Abstract] [Full Text] [PDF]

				N. Ajenjo, E. Canon, I. Sanchez-Perez, D. Matallanas, J. Leon, R. Perona, and P. Crespo Subcellular Localization Determines the Protective Effects of Activated ERK2 against Distinct Apoptogenic Stimuli in Myeloid Leukemia Cells J. Biol. Chem., July 30, 2004; 279(31): 32813 - 32823. [Abstract] [Full Text] [PDF]

				M.-T. Park, J.-A Choi, M.-J. Kim, H.-D. Um, S. Bae, C.-M. Kang, C.-K. Cho, S. Kang, H. Y. Chung, Y.-S. Lee, et al. Suppression of Extracellular Signal-related Kinase and Activation of p38 MAPK Are Two Critical Events Leading to Caspase-8- and Mitochondria-mediated Cell Death in Phytosphingosine-treated Human Cancer Cells J. Biol. Chem., December 12, 2003; 278(50): 50624 - 50634. [Abstract] [Full Text] [PDF]

				D. J. Taxman, J. P. MacKeigan, C. Clements, D. T. Bergstralh, and J. P-Y. Ting Transcriptional Profiling of Targets for Combination Therapy of Lung Carcinoma with Paclitaxel and Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase Inhibitor Cancer Res., August 15, 2003; 63(16): 5095 - 5104. [Abstract] [Full Text] [PDF]

				B. Zheng, P. Fiumara, Y. V. Li, G. Georgakis, V. Snell, M. Younes, J. N. Vauthey, A. Carbone, and A. Younes MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival Blood, August 1, 2003; 102(3): 1019 - 1027. [Abstract] [Full Text] [PDF]

				I. A. Vasilevskaya, T. V. Rakitina, and P. J. O'Dwyer Geldanamycin and its 17-Allylamino-17-Demethoxy Analogue Antagonize the Action of Cisplatin in Human Colon Adenocarcinoma Cells: Differential Caspase Activation as a Basis for Interaction Cancer Res., June 15, 2003; 63(12): 3241 - 3246. [Abstract] [Full Text] [PDF]

				J. Lai, J. Chien, J. Staub, R. Avula, E. L. Greene, T. A. Matthews, D. I. Smith, S. H. Kaufmann, L. R. Roberts**, and V. Shridhar** Loss of HSulf-1 Up-regulates Heparin-binding Growth Factor Signaling in Cancer J. Biol. Chem., June 13, 2003; 278(25): 23107 - 23117. [Abstract] [Full Text] [PDF]

				K.-C. Choi, C.-J. Tai, C.-R. Tzeng, N. Auersperg, and P. C.K. Leung Adenosine Triphosphate Activates Mitogen-Activated Protein Kinase in Pre-Neoplastic and Neoplastic Ovarian Surface Epithelial Cells Biol Reprod, January 1, 2003; 68(1): 309 - 315. [Abstract] [Full Text] [PDF]

				G. Nowak Protein Kinase C-alpha and ERK1/2 Mediate Mitochondrial Dysfunction, Decreases in Active Na+ Transport, and Cisplatin-induced Apoptosis in Renal Cells J. Biol. Chem., November 1, 2002; 277(45): 43377 - 43388. [Abstract] [Full Text] [PDF]

				Z. Tong, G. Singh, and A. J. Rainbow Sustained Activation of the Extracellular Signal-regulated Kinase Pathway Protects Cells from Photofrin-mediated Photodynamic Therapy Cancer Res., October 1, 2002; 62(19): 5528 - 5535. [Abstract] [Full Text] [PDF]

				V. Levresse, L. Marek, D. Blumberg, and L. E. Heasley Regulation of Platinum-Compound Cytotoxicity by the c-Jun N-Terminal Kinase and c-Jun Signaling Pathway in Small-Cell Lung Cancer Cells Mol. Pharmacol., September 1, 2002; 62(3): 689 - 697. [Abstract] [Full Text] [PDF]

				P. A. Hershberger, T. F. McGuire, W.-D. Yu, E. G. Zuhowski, J. H. M. Schellens, M. J. Egorin, D. L. Trump, and C. S. Johnson Cisplatin Potentiates 1,25-Dihydroxyvitamin D3-induced Apoptosis in Association with Increased Mitogen-activated Protein Kinase Kinase Kinase 1 (MEKK-1) Expression Mol. Cancer Ther., August 1, 2002; 1(10): 821 - 829. [Abstract] [Full Text] [PDF]

				K.-C. Choi, S. K. Kang, C.-J. Tai, N. Auersperg, and P. C. K. Leung Follicle-Stimulating Hormone Activates Mitogen-Activated Protein Kinase in Preneoplastic and Neoplastic Ovarian Surface Epithelial Cells J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2245 - 2253. [Abstract] [Full Text] [PDF]

				Y.-J. Lee, J.-W. Soh, N. M. Dean, C.-K. Cho, T.-H. Kim, S.-J. Lee, and Y.-S. Lee Protein Kinase C{delta} Overexpression Enhances Radiation Sensitivity via Extracellular Regulated Protein Kinase 1/2 Activation, Abolishing the Radiation-induced G2-M Arrest Cell Growth Differ., May 1, 2002; 13(5): 237 - 246. [Abstract] [Full Text] [PDF]

				C. Yu, G. Krystal, L. Varticovksi, R. McKinstry, M. Rahmani, P. Dent, and S. Grant Pharmacologic Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase/Mitogen-activated Protein Kinase Inhibitors Interact Synergistically with STI571 to Induce Apoptosis in Bcr/Abl-expressing Human Leukemia Cells Cancer Res., January 1, 2002; 62(1): 188 - 199. [Abstract] [Full Text] [PDF]

				B. A. Ballif and J. Blenis Molecular Mechanisms Mediating Mammalian Mitogen-activated Protein Kinase (MAPK) Kinase (MEK)-MAPK Cell Survival Signals Cell Growth Differ., August 1, 2001; 12(8): 397 - 408. [Full Text] [PDF]

				P. Dent and S. Grant Pharmacologic Interruption of the Mitogen-activated Extracellular-regulated Kinase/Mitogen-activated Protein Kinase Signal Transduction Pathway: Potential Role in PromotingCytotoxic Drug Action Clin. Cancer Res., April 1, 2001; 7(4): 775 - 783. [Full Text]

				D. L. Persons, E. M. Yazlovitskaya, and J. C. Pelling Effect of Extracellular Signal-regulated Kinase on p53 Accumulation in Response to Cisplatin J. Biol. Chem., November 10, 2000; 275(46): 35778 - 35785. [Abstract] [Full Text] [PDF]

				X. Wang, J. L. Martindale, and N. J. Holbrook Requirement for ERK Activation in Cisplatin-induced Apoptosis J. Biol. Chem., December 8, 2000; 275(50): 39435 - 39443. [Abstract] [Full Text] [PDF]